A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Re...

Time：2021/8/17 9:56:57

25% of colorectal cancer patients will experience peritoneal metastases (CCPM) due to its natural of serosa in?ltration, with a 5-year survival rate less than 10% in clinic. CCPM, which is multiple and scattered, is the terminal stage of colorectal cancer,...

+More

Biomimetic Dendrimer-Peptide Conjugates for Early Multi‐Target Therapy of Alzhe...

Time：2021/5/19 16:57:18

Recently, our group has developed a biomimetic dendrimer-peptide nanoconjugate, which had the function of regulating the pro-inflammatory microenvironment of brain lesions and was used for early multi-target treatment of Alzheimer’s disease (AD). The relevan...

+More

Journal of Controlled Release: Postoperative Cancer Treatments: In-situ Delivery...

Time：2021/1/8 20:37:39

A review: Link address:https://doi.org/10.1016/j.jconrel.2020.12.038

+More

ACS Appl. Mater. Interfaces: Click-Nucleic-Acid-Containing Codelivery System Ind...

Time：2021/1/8 20:27:41

Recently, our research group developed a click-nucleic-acid-containing platform for codelivery of rapamycin, anti-PFKFB4 siRNA, and targeting ligand aptamer AS1411. The relevant studies were published online in ACS Applied Materials and Interfaces (IF=8.758),...

+More

Biomaterials: Pancreatic cancer-targeting exosomes for enhancing immunotherapy a...

Time：2020/12/3 20:34:53

Pancreatic Cancer-Targeting Exosomes for Enhancing Immunotherapy and Reprogramming Tumor Microenvironment Recently, we developed an exosome-based dual delivery biosystem(iEXO-OXA) for enhancing PDAC immunotherapy as well as reversing tumor immunosuppression o...

+More